24 January 2024
Oxford PharmaGenesis has contributed to the development of the new ACCORD reporting guideline to help the medical and scientific communities to improve the reporting of research involving consensus methodologies. The guideline was published in the non-profit open access journal PLOS Medicine.
Oxford PharmaGenesis has been shortlisted for the Communiqué Awards 2022 for the Award for Excellence in Public Health Communications for MS Brain Health, on behalf of Oxford Health Policy Forum. This global policy initiative has changed the way that leading multiple sclerosis (MS) experts view best practice in MS care.
Citation (title and abstract) screening for a systematic literature review may be accelerated by 25% through the application of artificial intelligence (AI) in a novel method developed by Oxford PharmaGenesis in partnership with Vyasa. The evidence reported in systematic literature reviews derives from articles that have passed a rigorous screening process. According to a recent study, our new,…
Creativity, diversity, data visualization and plain language summaries all took centre stage at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP), which took place on 9–11 May 2022 in Washington, DC, USA.
Share this page As study finds that 95% of the top pharmaceutical companies worldwide aim to cut greenhouse gas emissions, commitments will require innovation and collaboration across the supply chain. Washington, DC, USA, 10 May 2022: According to a study presented at the 18th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) today, 19…
Oxford PharmaGenesis is proud to sponsor the MAPS 2022 EMEA Annual Meeting – the largest annual convention for Medical Affairs professionals in Europe, the Middle East and Africa. We are an award-winning, independent, global HealthScience consultancy. We take clients to new places with a range of transformative services. Our teams use innovative approaches, such as informatics, to explore new frontiers in strategic medical communications, informatics and data science, patient engagement, e-learning and value demonstration.
We’re helping medical publication professionals become future-ready at the 18th Annual Meeting of ISMPP 2022. Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy. We innovate for clients through our transformative services. We offer expertise in publications, strategic medical communications, informatics and data science, patient engagement, value demonstration and Open Pharma.
